Clinical Trials Directory

Trials / Unknown

UnknownNCT03060655

Study of PLGA-Mg Material in Clinical Orthopedics

Randomized, Double Blind Trial of Study of PLGA-Mg Material in Clinical Orthopedics

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Hebei Medical University Third Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The different proportion samples of PLGA-Mg were made in this study. Then, they would be placed in the femoral condyle of the New Zealand rabbits. The appropriate proportion of PLGA-Mg is obtained after the experiment, which will be used to make the plate or screw to fix the fragments. Then, the clinical role for bone will be assessed.

Detailed description

The deposition of calcium could be facilitated by the increase of magnesium, which played an important role in fracture union. However, its degradation may be completed before the fracture line was disappeared. In addition, the hydrogen may be released during degradation. Thus, its clinical popularization was limited. As a new polymer material, poly lactic-co-glycolic acid (PLGA) has been widely used clinically. The hydrolytic production of PLGA was acidic, which could neutralize the alkalinity of production degraded from magnesium. In addition, it was a long time before the total accomplishment of degradation of PLGA, which may postpone the degradation of magnesium. The different proportion samples of PLGA-Mg were made in this study. Their physical and chemical properties were analyzed to estimate its safety of implantation. Then, they would be placed in the femoral condyle of the New Zealand rabbits. The osteogenesis and complication of samples are examined to select an appropriate proportion of PLGA-Mg is obtained. Then, the PLGA-Mg material will be used to fix the fracture of human as a fixation. The review of the patients will be conducted to assess its clinical role.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPLGA-Mg materialThe PLGA-Mg material was used to accomplish the fixation of fragments. Then, the clinical outcome was assessed.
BIOLOGICALtitanium alloyTraditional fixation was titanium alloy. the clinical outcome was assessed.

Timeline

Start date
2016-08-01
Primary completion
2018-02-01
Completion
2018-03-01
First posted
2017-02-23
Last updated
2017-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03060655. Inclusion in this directory is not an endorsement.